Trodelvy

Teva snares up to $150M in Abingworth funding to propel late-stage asthma rescue inhaler
Fierce Pharma
Mon, 04/1/24 - 12:02 pm
Teva Pharmaceutical
Trodelvy
TEV-248
Abingworth
Gilead Secures $210M from VC to Build Trodelvy’s Clinical Case in NSCLC
BioSpace
Fri, 03/1/24 - 11:48 am
Gilead Sciences
funding
Trodelvy
non-small cell lung cancer
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Gilead's Trodelvy fails to extend survival in lung cancer study, prompting selloff
Fierce Pharma
Mon, 01/22/24 - 11:21 am
Gilead Sciences
antibody-drug conjugate
Trodelvy
lung cancer
clinical trials
Could Gilead’s Trodelvy be the next TROP-2 therapy game-changer in NSCLC treatment?
Clinical Trials Arena
Fri, 09/22/23 - 12:00 pm
Gilead Sciences
Trodelvy
TROP-2
non-small cell lung cancer
Gilead unveils promising data from trial of combo therapy for lung cancer
Clinical Trials Arena
Mon, 09/11/23 - 12:34 pm
Gilead Sciences
Trodelvy
metastatic non-small cell lung cancer
Gilead antibody drug shows signs of potential in early lung cancer
BioPharma Dive
Thu, 08/17/23 - 10:03 am
Gilead Sciences
Trodelvy
Merck
Keytruda
lung cancer
Former Immunomedics CFO pleads guilty to securities fraud over Trodelvy tip
Fierce Biotech
Thu, 05/18/23 - 10:51 am
Immunomedics
Usama Malik
insider trading
legal
Trodelvy
Gilead reports positive data from urothelial cancer therapy trial cohorts
Clinical Trials Arena
Mon, 02/20/23 - 12:51 pm
Gilead Sciences
Trodelvy
metastatic urothelial cancer
clinical trials
Gilead's Trodelvy snags vital breast cancer nod
Fierce Pharma
Mon, 02/6/23 - 10:44 am
Gilead Sciences
FDA
Trodelvy
breast cancer
HR-positive HER-negative breast cancer
Gilead Sciences to provide Trodelvy for Strata PATH trial
Clinical Trials Arena
Thu, 01/19/23 - 07:48 pm
Gilead Sciences
Strata Oncology
Trodelvy
clinical trials
5 FDA decisions to watch in the first quarter
BioPharma Dive
Mon, 01/9/23 - 10:27 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Menareni
Elacestrant
breast cancer
Biomarin
Roctavian
hemophilia A
Acadia Pharmaceuticals
trofinetide
Rett Syndrome
Gilead Sciences
Trodelvy
After a rocky few months, Gilead's Trodelvy keeps recent winning streak rolling with priority review
Fierce Pharma
Tue, 10/11/22 - 04:08 pm
Gilead Sciences
breast cancer
Trodelvy
ESMO
FDA
priority review
ESMO: Gilead's Trodelvy makes surprise comeback with above-par breast cancer survival showing
Fierce Pharma
Wed, 09/7/22 - 11:59 pm
Gilead Sciences
Trodelvy
ESMO
HR-positive HER-negative breast cancer
breast cancer
After Trodelvy's approval in China, Gilead strikes $455M deal with Everest for Asian rights
Fierce Pharma
Tue, 08/16/22 - 12:36 pm
Gilead Sciences
Immunomedics
Trodelvy
Everest Medicines
ASCO: Gilead's Trodelvy limps forward in new breast cancer lane as below-par showing casts doubt
Fierce Pharma
Sun, 06/5/22 - 11:42 pm
Gilead Sciences
Trodelvy
breast cancer
ASCO 2022
3 cancer drug studies to watch at next month’s ASCO meeting
BioPharma Dive
Thu, 05/26/22 - 10:47 pm
ASCO 2022
AstraZeneca
Enhertu
Gilead Sciences
Trodelvy
Roche
tiragolumab
cancer
Gilead’s Covid-19 treatment Veklury props up first quarter gains amid $2.7B Trodelvy writedown
Endpoints
Fri, 04/29/22 - 10:31 am
Gilead Sciences
Veklury
remdesivir
earnings
Trodelvy
Gilead, after setbacks, aims to pull a third of its revenue from oncology business by 2030
Fierce Pharma
Mon, 04/18/22 - 11:47 pm
Gilead Sciences
oncology
cancer
Yescarta
Trodelvy
That key Gilead breast cancer readout? Try 2024, and don't get your hopes up: analyst
Fierce Pharma
Wed, 03/9/22 - 10:51 am
Gilead Sciences
Trodelvy
breast cancer

Pages